Free Trial
CVE:VPT

VentriPoint Diagnostics (VPT) Stock Price, News & Analysis

VentriPoint Diagnostics logo
C$0.16 -0.01 (-6.06%)
As of 02:24 PM Eastern

About VentriPoint Diagnostics Stock (CVE:VPT)

Key Stats

Today's Range
C$0.16
C$0.17
50-Day Range
C$0.10
C$0.16
52-Week Range
C$0.08
C$0.22
Volume
113,000 shs
Average Volume
200,431 shs
Market Capitalization
C$25.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VentriPoint Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

VPT Stock News Headlines

Ventripoint Diagnostics Ltd. (VPT.V) - Yahoo Finance
A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
See More Headlines

VPT Stock Analysis - Frequently Asked Questions

VentriPoint Diagnostics' stock was trading at C$0.10 at the start of the year. Since then, VPT stock has increased by 55.0% and is now trading at C$0.16.

Shares of VPT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that VentriPoint Diagnostics investors own include Resverlogix (RVX), Meta Platforms (META), Sphere 3D (ANY), Aptose Biosciences (APTO), Antibe Therapeutics (ATE), AuRico Gold Inc. Ordinary Share (AUQ) and Baytex Energy (BTE).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
CVE:VPT
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$5.25 million
Net Margins
-3,732.10%
Pretax Margin
N/A
Return on Equity
388.60%
Return on Assets
-136.72%

Debt

Debt-to-Equity Ratio
-58.56
Current Ratio
0.28
Quick Ratio
6.67

Sales & Book Value

Annual Sales
C$140.67 thousand
Price / Sales
178.73
Cash Flow
C$0.03 per share
Price / Cash Flow
5.53
Book Value
C($0.02) per share
Price / Book
-9.92

Miscellaneous

Outstanding Shares
162,204,000
Free Float
N/A
Market Cap
C$25.14 million
Optionable
Not Optionable
Beta
0.39
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (CVE:VPT) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners